16:19 ETHims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following Major FTC Lawsuit Over Privacy & Billing; Hagens Berman Investigates Corporate Compliance and Investor Ramifications
prnewswire·- Hims & Hers Health, Inc. stock plunged 14.73 % to close at $25.00 following a federal lawsuit filed by the FTC and co-plaintiffs on July 29, 2026. - The lawsuit alleges deceptive health data sharing with third-party advertisers and subscription billing violations under the Restore Online Shoppers' Confidence Act. - Shareholders rights firm Hagens Berman subsequently opened an investigation into the company's corporate compliance, internal controls, and financial reporting disclosures.19:55 ETKessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm
prnewswire·- Kessler Topaz Meltzer & Check, LLP is investigating potential federal securities law violations by Hims & Hers Health, Inc. on behalf of injured investors. - The investigation follows a July 29, 2026, FTC lawsuit accusing Hims & Hers of deceptively sharing sensitive patient medical information with third-party advertisers like Meta and Snap. - Following the lawsuit announcement, Hims & Hers stock price dropped by over 14 %, prompting the law firm to invite affected investors to discuss their legal rights.